Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

DMD – THERAPY: P.291 Real-world evidence of eteplirsen treatment effects on Duchenne muscular dystrophy related health outcomes using claims data in the United States

Autor: Iff, J., Tuttle, E., Gerrits, C., Gupta, D., Zhong, Y.

Publikováno v: In Neuromuscular Disorders October 2020 30 Supplement 1:S131-S132

A beam experiment on excimer formation in collisions of Kr*(3P0), Kr*(3P2), and Xe* atoms with Br-containing molecules.

Autor: Vredenbregt, E. J. D., van Besouw, M. P. M., Vrakking, M. J. J., Mietus, M. J., Gerrits, C. E. P., Beijerinck, H. C. W.

Publikováno v: Journal of Chemical Physics; 5/15/1993, Vol. 98 Issue 10, p7903, 23p

N-acetylcysteine is unlikely to reduce hospitalisation for chronic obstructive pulmonary disease (multiple letters) [1]

Autor: Ernst, P., Suissa, S., Gerrits, C. M.J.M., Herings, R. M.C., Leufkens, H. G.M., Lammers, J. W.J.

Publikováno v: European Respiratory Journal, 22(5), 865-866. European Respiratory Society
Ernst, P, Suissa, S, Gerrits, C M J M, Herings, R M C, Leufkens, H G M & Lammers, J W J 2003, ' N-acetylcysteine is unlikely to reduce hospitalisation for chronic obstructive pulmonary disease (multiple letters) [1] ', European Respiratory Journal, vol. 22, no. 5, pp. 865-866 . https://doi.org/10.1183/09031936.03.00063403

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::6699b88be3603baaee1a533e99830e21
https://research.vumc.nl/en/publications/9f639cd7-fbad-4ded-9392-86c860cb1f65

Asthma exacerbations during first therapy with long acting beta 2-agonists

Autor: Gerrits, C. M., Herings, R. M., Leufkens, H. G., Lammers, J. W.

Publikováno v: Gerrits, C M, Herings, R M, Leufkens, H G & Lammers, J W 1999, ' Asthma exacerbations during first therapy with long acting beta 2-agonists ', Pharmacy World and Science, vol. 21, no. 3, pp. 116-119 . https://doi.org/10.1023/a:1008618700934
Pharmacy World and Science, 21(3), 116-119. Kluwer Academic Publishers

Long-acting beta 2-agonists (LBA) have become an important therapeutic strategy in the treatment of asthma. There is, however, debate whether LBA increase the risk of asthma exacerbations (AE). We studied whether the risk of AE was increased in patie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1701bb3baeab758d94e4dc867d2d8079
https://research.vumc.nl/en/publications/e8e9fded-3853-4f4e-97ea-1bfb95b0ad06